Why the study?
The study aimed to assess repair success, durability, survival, and intraoperative outcomes following minimally-invasive repair of symmetric and asymmetric Barlow disease.
Does minimally-invasive annuloplasty-only compared to annuloplasty plus neochords provide safe and durable repair in patients with Barlow's disease?
Population
103 patients presenting with Barlow disease
Comparison
Annuloplasty plus neochords vs annuloplasty-only
Design
Observational cohort study
Key result
Minimally-invasive mitral valve repair for Barlow's disease achieved a 100% repair success rate in the analyzed cohort, demonstrating that annuloplasty-only is a viable approach for symmetric pathologies.
Authors
Loading...
Annuloplasty-only may shorten cross-clamp times in symmetric Barlow's but raises SAM risk; leaves open need for randomized comparison on durability.
Cohort (n=102)
No
Does minimally-invasive annuloplasty-only compared to annuloplasty plus neochords provide safe and durable repair in patients with Barlow's disease?
Absolute Event Rate: 100% vs 100%
Minimally-invasive annuloplasty-only is a feasible and durable approach for symmetric Barlow's disease, offering shorter cross-clamp times but carrying a higher risk of intraoperative systolic anterior motion compared to annuloplasty with neochords.
Faerber et al. (2021) conducted a cohort in Barlow's disease (n=102). Annuloplasty only vs. Annuloplasty plus neochords was evaluated on Success rate of mitral valve repair. Minimally-invasive mitral valve repair for Barlow's disease achieved a 100% repair success rate in the analyzed cohort, demonstrating that annuloplasty-only is a viable approach for symmetric pathologies.